Fas receptor clustering and involvement of the death receptor pathway in rituximab-mediated apoptosis with concomitant sensitization of lymphoma B cells to Fas-induced apoptosis

被引:74
作者
Stel, Alia J.
ten Cate, Bram
Jacobs, Susan
Kok, Jan Willem
Spierings, Diana C. J.
Dondorff, Monica
Helfrich, Wijnand
Kluin-Nelemans, Hanneke C.
de Leij, Lou F. A. H.
Withoff, Sebo
Kroesen, Bart Jan
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Lab Med, Sect Med Biol,Lab Tumor Immunol, NL-9713 GZ Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Membrane Cell Biol, NL-9713 GZ Groningen, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, NL-9713 GZ Groningen, Netherlands
[4] St Jude Childrens Hosp, Dept Immunol, Memphis, TN 38105 USA
关键词
D O I
10.4049/jimmunol.178.4.2287
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Ab binding to CD20 has been shown to induce apoptosis in B cells. In this study, we demonstrate that rituximab sensitizes lymphoma B cells to Fas-induced apoptosis in a caspase-8-dependent manner. To elucidate the mechanism by which Rituximab affects Fas-mediated cell death, we investigated rituximab-induced signaling and apoptosis pathways. Rituximab-induced apoptosis involved the death receptor pathway and proceeded in a caspase-8-dependent manner. Ectopic overexpression of FLIP (the physiological inhibitor of the death receptor pathway) or application of zIETD-fmk (specific inhibitor of caspase-8, the initiator-caspase of the death receptor pathway) both specifically reduced rituximab-induced apoptosis in Ramos B cells. Blocking the death receptor ligands Fas ligand or TRAIL, using neutralizing Abs, did not inhibit apoptosis, implying that a direct death receptor/ligand interaction is not involved in CD20-mediated cell death. Instead, we hypothesized that rituximab-induced apoptosis involves membrane clustering of Fas molecules that leads to formation of the death-inducing signaling complex (DISC) and downstream activation of the death receptor pathway. Indeed, Fas coimmune precipitation experiments showed that, upon CD20-cross-linking, Fas-associated death domain protein (FADD) and caspase-8 were recruited into the DISC. Additionally, rituximab induced CD20 and Fas translocation to raft-like domains on the cell surface. Further analysis revealed that, upon stimulation with rituximab, Fas, caspase-8, and FADD were found in sucrose-gradient raft fractions together with CD20. In conclusion, in this study, we present evidence for the involvement of the death receptor pathway in rituximab-induced apoptosis of Ramos B cells with concomitant sensitization of these cells to Fas-mediated apoptosis via Fas multimerization and recruitment of caspase-8 and FADD to the DISC.
引用
收藏
页码:2287 / 2295
页数:9
相关论文
共 43 条
[1]  
Alas S, 2001, CANCER RES, V61, P5137
[2]  
Alas S, 2002, CLIN CANCER RES, V8, P836
[3]  
Alas S, 2001, CLIN CANCER RES, V7, P709
[4]   Molecular ordering of the initial signaling events of CD95 [J].
Algeciras-Schimnich, A ;
Shen, L ;
Barnhart, BC ;
Murmann, AE ;
Burkhardt, JK ;
Peter, ME .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (01) :207-220
[5]   Caspase-3 is a component of fas death-inducing signaling complex in lipid rafts and its activity is required for complete caspase-8 activation during Fas-mediated cell death [J].
Aouad, SM ;
Cohen, LY ;
Sharif-Askari, E ;
Haddad, EK ;
Alam, A ;
Sekaly, RP .
JOURNAL OF IMMUNOLOGY, 2004, 172 (04) :2316-2323
[6]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]   Recruitment, activation and retention of caspases-9 and-3 by Apaf-1 apoptosome and associated XIAP complexes [J].
Bratton, SB ;
Walker, G ;
Srinivasula, SM ;
Sun, XM ;
Butterworth, M ;
Alnemri, ES ;
Cohen, GM .
EMBO JOURNAL, 2001, 20 (05) :998-1009
[8]   Target cell-restricted and -enhanced apoptosis induction by a scFv:sTRAIL fusion protein with specificity for the pancarcinoma-associated antigen EGP2 [J].
Bremer, E ;
Kuulen, J ;
Samplonius, D ;
Walczak, H ;
De Leu, L ;
Helfrich, W .
INTERNATIONAL JOURNAL OF CANCER, 2004, 109 (02) :281-290
[9]   The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis induction [J].
Byrd, JC ;
Kitada, S ;
Flinn, IW ;
Aron, JL ;
Pearson, M ;
Lucas, N ;
Reed, JC .
BLOOD, 2002, 99 (03) :1038-1043
[10]  
Chow KU, 2002, HAEMATOLOGICA, V87, P33